Noah is a six-year-old suffering from a disorder without a name. This year, his physicians will begin sending his genetic information across the Internet to see if there’s anyone, anywhere, in the world like him.
A match could make a difference. Noah is developmentally delayed, uses a walker, speaks only a few words. And he’s getting sicker. MRIs show that his cerebellum is shrinking. His DNA was analyzed by medical geneticists at the Children’s Hospital of Eastern Ontario. Somewhere in the millions of As, Gs, Cs, and Ts is a misspelling, and maybe the clue to a treatment. But unless they find a second child with the same symptoms, and a similar DNA error, his doctors can’t zero in on which mistake in Noah’s genes is the crucial one.
Martxoaren 11n, Arrasateko Garaia Berrikuntza Gunean Komunikaldia jardunaldiaren 10. edizioa egingo da. Humanitate eta Hezkuntza Zientzien Fakultateak antolatzen duen jardunaldiak porrotaren gaia jorratuko du, hain zuzen ere, komunikazio eta ikus-entzunezko proiektuen porrotetatik atera daitezkeen irakaspenak eta, ondoren, berriro ahalegintzeak duen garrantzia.
The commonly found adenovirus poses little problem for healthy people, whose immune systems can fight the respiratory and gastrointestinal infections the virus can cause. But in bone marrow and organ transplant patients, adenovirus often becomes deadly. Their weakened immune systems can’t fight off the virus, which studies show can be fatal in up to 80 percent of such cases.
Clearside Biomedical, Inc., a clinical-stage biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye, today announced the enrollment of the first patient in a Phase 2 randomized, controlled, masked, multi-center clinical trial for the treatment of macular edema associated with retinal vein occlusion (RVO) using Clearside’s proprietary formulation of triamcinolone acetonide, CLS-TA, administered via suprachoroidal (SCS) injection using Clearside’s proprietary microinjector.
La cooperativa especializada en máquina herramienta ha instalado un equipamiento de corte por láser fibra de 1500x4000 milímetros en la empresa italiana especializada en ventilación Kaer Industrial Ventilation.
La máquina de Danobat consiste en un equipamiento de corte por láser de fibra, equipado con un sistema automático
La 3ª edición del "Polymers & Medical Applications" se llevará a cabo el día 18 de Marzo en el Auditorium, Lea-Artibai Berrikuntza Gunea. Xemein Etorbidea, 12A, en Markina-Xemein.
La jornada se desarrollará conforme al programa adjunto:
Bi erakundeen arteko hitzarmena Bizkaiko Foru Aldundiko ekonomiaren sustapenerako Bizkaia Talent programa barruan dago, esne sektorean ezagutza zabaltzeko asmoarekin gero Bizkaiko lurraldean barrena abeltzaintzako proiektu ezberdinetan eta deribatuetan aplikatzeko helburuarekin.
Halaber, proiektuaren garapenerako hainbat euskal gazta ekoizle artisauen eta merkaturatzeko eragile espezialisten arteko kontaktua sustatuko dute sektoreko lehiakortasun ekimenak bultzatzeko asmoz.
Europa mailako lehen Nekazal Ikerketa institutua eta mundu mailan bigarrena Gilles Garric nazioarte mailan ikertzaile ezaguna da, Frantziako Rennes (Bretinia) herrian dagoen Science and Technologuie du Lait et de l'oeuf - INRA unitatean lan egiten du.
Self-driving cars generate a lot of headlines. But there’s already a new kind of car on the road that’s completely changing the vehicle market.
The connected car is equipped with Internet connections and software that allow people to stream music, look up movie times, be alerted of traffic and weather conditions, and even power driving-assistance services such as self-parking.
Como cada inicio de mes, repasamos las inversiones más importantes que se han cerrado en el sector de las startups tecnológicas en España durante el mes anterior, en este caso el segundo de este año 2015.
Descripción: Captio ha desarrollado una solución basada en la digitalización de los justificantes de gastos y extracción de sus datos, a través de smartphones,para la automatización del proceso de creación y supervisión de las notas de gastos que realizan los trabajadores en movilidad. .
